Krementz E T, Carter R D, Sutherland C M, Hutton I
Ann Surg. 1977 May;185(5):555-64. doi: 10.1097/00000658-197705000-00008.
From 1957 to 1975, 113 patients with sarcoma of the extremities have been treated with chemotherapy by regional perfusion, either alone or as an adjunct to excisional surgery. Perfusion alone in 54 patients was associated with an early response rate of 83%, but only four patients had complete regression of tumor for longer than three months. When perfusion was followed by immediate or delayed excision, better results were obtained. In 49 Stage I patients and in 24 Stage II patients, cumulative survivals of 66% and 59% were obtained at five years and 66% and 51% at 10 years. The procedure has also been useful in saving functional limbs by converting tumors to operability, and in the palliation of pain and ulceration.
1957年至1975年间,113例肢体肉瘤患者接受了区域灌注化疗,或单独使用,或作为切除手术的辅助手段。54例单独接受灌注治疗的患者早期缓解率为83%,但只有4例患者肿瘤完全消退超过3个月。当灌注后立即或延迟进行切除时,可获得更好的效果。在49例I期患者和24例II期患者中,5年累积生存率分别为66%和59%,10年累积生存率分别为66%和51%。该方法在通过将肿瘤转化为可手术切除来挽救功能肢体以及缓解疼痛和溃疡方面也很有用。